Clover cancels AIM listing
Thursday, 19 January, 2006
Sydney-based Clover (ASX:CLV) has applied to the London Stock Exchange to cancel its listing on the Alternative Investment Market (AIM).
The cancellation is expected to take effect from February 16.
Clover's board felt that the costs associated with maintaining a dual listing on AIM and the ASX outweighed any benefits gained and the company will not be looking to raise new capital on AIM in the foreseeable future. All shareholdings registered in the UK on AIM will be automatically transferred following the delisting and will remain tradable as ordinary shares on the ASX.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
